Gene Query: STUB1

Dataset Description Geneva Score
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 75.7
SUV420H2 knockdown in PANC-1 41.43
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 34.62
Co-regulation of splicing by Rbfox1 and hnRNP M 34.62
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 23.68
Genome wide expression change by RNF168 knocking down in MCF-7 cells 23.56
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 23.54
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 21.75
Role of XRN2 ribonucleolytic activity in RNA metabolism 20.71
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 19.35
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 19.3
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 18.94
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 18.74
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 18.12
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 17.63
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 17.28
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 17.1
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 16.79
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 16.68
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 16.29
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 16.1
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 16.1
Stem and effector CD8 T-cells from human cancers 16.06
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 15.39
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 15.24
Regulation of highly expressed hCINAP on translatome 15.15
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 15.06
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 15.06
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 15.06
The comparison of high-throughput single-cell RNA-seq methods 14.78
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 14.77
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.49
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 14.42
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 14.35
Lipid degradation promotes prostate cancer cell survival 14.22
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.17
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 14.1
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.86
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.56
Uridylation by TUT4 and TUT7 marks mRNA for degradation 13.31
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 13.29
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 13.11
High-Throughput Kinetic Analysis of Fractional Killing 13.09
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 12.99
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 12.97
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 12.8
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 12.68
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.63
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.63
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.56
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 12.54
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.49
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 12.44
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 12.37
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 12.15
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 12.15
Transcriptional effect of ETV1 knockdown in melanoma cells 12.09
SNHG5 siRNA knock down in HCT116 cells 12.05
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 11.87
Triple vectors expand AAV transfer capacity in the retina 11.58
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 11.28
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.24
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 11.02
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 10.95
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 10.92
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.91
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 10.89
Gene expression profiling of leukemia cells following asparagine depletion 10.88
Effect of CHKA knockdown on C4-2 cell transcriptome 10.73
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 10.49
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.44
Genome wide expression change by RNF168 knocking down in NEC cells 10.34
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 10.33
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 10.31
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 10.25
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.24
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 10.18
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 10.07
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 10.06
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 10.02
U1 snRNP telescripting regulates size-function stratified human genome 10.0
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 9.98
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.94
Global analysis of enhancer targets: Mosaic-seq 9.88
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 9.78
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.76
Cajal bodies are linked to genome conformation [RNA-Seq] 9.67
Cajal bodies are linked to genome conformation 9.67
PNET animal model: new insights (II) 9.64
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 9.57
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 9.56
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 9.56
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 9.43
Transcriptome of U251 cells overexpression complement component 7 9.42
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 9.37
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.33
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.31
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.29
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.26
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.26
RNA-seq analysis of uveal melanoma cells treated with FR900359 9.18
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.16
TCF7L1 knockdown in pancreatic cancer 8.89
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 8.87
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 8.84
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.83
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.78
Global analysis of alternative splicing regulated by RBM10 8.69
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.65
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 8.64
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 8.64
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 8.62
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.61
RNA-seq in transgenic cells 8.57
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.51
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.51
High-throughput sequencing of pluripotent cells 8.51
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 8.51
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 8.47
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 8.43
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 8.43
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.43
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 8.38
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.37
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.37
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 8.3
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 8.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 8.29
RNAseq analysis of ESRP regulated splicing events in prostate cancer 8.24
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.16
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.16
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.16
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 8.16
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 8.16
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.92
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.91
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.9
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.89
N6-methyladenine DNA Modification in Glioblastoma 7.89
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.85
Differential gene expression of human melanoma cells [RNA-seq] 7.85
CROP-Seq in Primary Human T Cells 7.85
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.84
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.82
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 7.82
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 7.8
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.75
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.74
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.72
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.68
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.65
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.65
The landscape of alternative splicing in aggressive prostate cancers 7.64
RNA-seq analyses of human prostate cancer cells 7.57
The cohesin complex prevents Myc-induced replication stress 7.56
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 7.54
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.49
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.47
Proteomics identifies a marker signature of MAPKi resistance in melanoma 7.45
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.44
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 7.42
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 7.39
A practical evaluation of alignment algorithms for RNA variant calling analysis 7.28
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 7.26
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.24
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.23
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.17
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.17
METTL3 and WTAP 7.14
Total RNA sequencing of WT intestinal orgaonids. 7.09
SRSF1 role in cellular gene expression and splicing 7.07
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 7.07
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.04
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.04
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 7.04
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 7.03
METTL3 promotes translation in human cancer cells 7.03
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 7.02
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 7.0
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.97
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.96
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.96
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.92
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.92
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.91
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.91
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 6.88
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 6.88
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.86
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.85
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.84
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.84
Impact of dieldrin on transcription in Jurkat T cells 6.77
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.71
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.68
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.68
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 6.66
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.66
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 6.65
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 6.6
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 6.6
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.58
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.48
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 6.46
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.44
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.44
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.38
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 6.37
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 6.37
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 6.33
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.25
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 6.24
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.23
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.2
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.19
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.19
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.17
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.14
Transcriptome sequencing of K-562 cells 6.13
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.08
RNAseq of cell lines with knocked in ESR1 mutations 6.02
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 5.98
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 5.96
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 5.89
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.73
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.71
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.7
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.7
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.67
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.66
LncRNA expression profiling of ischemic stroke patients 5.63
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 5.62
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.6
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 5.52
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.47
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.42
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.41
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.41
RNA-seq of cells with TET1 knockout 5.39
Human Treg NaCl stimulation 5.36
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.36
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.33
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.33
Lysine benzoylation is a novel histone mark [RNA-seq] 5.33
Lysine benzoylation is a novel histone mark 5.33
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.32
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.31
RNA-seq of YB5 cells treated with Proscillaridin A 5.28
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.26
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.26
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.23
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 5.21
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.18
CD86 regulates a pro-survival signal in myeloma cells 5.17
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.16
Functional role of CPPED1 in trophoblasts. 5.16
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 5.09
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.07
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.03
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.0
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.98
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.97
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.97
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.96
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.96
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.92
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.9
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.89
miRNAs affected by antagomiR-17 treatment 4.89
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.86
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.83
Gene expression signatures of innate lymphoid cells from human blood 4.83
Effect of FGF13 depletion on the H460 cell line 4.81
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.76
RNA splicing alteration on glioblastoma and normal neural stem cells 4.73
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.71
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.68
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.68
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.65
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 4.64
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 4.64
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.62
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 4.54
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.46
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.45
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.43
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.43
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.4
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 4.4
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.39
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.33
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.29
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.29
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.25
Illumina Total RNA-seq in HeLa 4.23
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.22
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.22
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.19
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.19
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.18
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.15
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.1
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.04
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.04
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.0
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.99
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.99
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.98
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.92
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.91
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.89
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.88
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 3.85
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 3.81
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.79
Differential responses of human fetal brain neural stem cells to Zika virus infection 3.78
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.73
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 3.69
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.69
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.64
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.64
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.64
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 3.63
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.61
Identification of long noncoding RNAs regulated by p53 3.59
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.58
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.57
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.54
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.52
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.44
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.44
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.41
X-Ray induced DNA-Hydroxymethylation changes 3.39
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.36
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.36
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.36
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.28
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.28
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 3.25
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 3.25
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.22
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 3.2
Transciptomic profiling of human fetal lung samples 3.1
PRDM1 inhibits proliferation of human colon cancer organoids 3.06
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.01
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.0
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.99
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.96
HEK293 TFAM Knockout Expression Study 2.96
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.9
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.88
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.85
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Ebola virus (EBOV) infection of ARPE-19 cells 2.79
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.78
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.78
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.78
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.78
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.78
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.77
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.77
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.71
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.71
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.71
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.58
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.57
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.55
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.51
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.51
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.48
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 2.45
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.44
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 2.42
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.42
TT-Seq captures the human transient transcriptome 2.42
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.4
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.33
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.32
Gene expression changes due to PARP knockdown in human cells 2.3
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.26
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.26
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.25
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.25
Global response to chemotherapy-induced apoptosis 2.2
Functional significance of the HIV-1 Tat signature amino acid residues 2.18
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.16
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.16
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.13
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.08
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.08
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.06
RNA editing in nascent RNA affects pre-mRNA splicing 2.04
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 2.03
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.02
Ribosome profiling upon inhibition of eIF4A 2.02
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.01
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.0
Investigate A2M treatment on human prostate cancer xenograft in mice 1.98
Investigate A2M treatment on human prostate cancer and mouse liver 1.98
Comparative Analysis of Cas9 Activators Across Multiple Species 1.96
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.93
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.93
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.92
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.91
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.86
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.85
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.83
miR-93 Targets in Human Endothelial Cells 1.82
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.8
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.79
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.73
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.68
Iron response of HepG2 cells 1.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.65
Interaction between mitoNEET and NAF-1 in cancer cells 1.65
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.64
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.64
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.6
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.58
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.57
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.56
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.56
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.55
Positively selected enhancer elements endow tumor cells with metastatic competence 1.55
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.52
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 1.5
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.49
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.49
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.48
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.45
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.28
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.28
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.26
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.15
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.1
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.07
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.06
m6A-dependent regulation of messenger RNA stability 1.04
RNA-sequencing of healthy human skeletal myocytes 1.03
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.02
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.01
Transcriptomic analysis of LSD1 1.0
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.97
Copper Regulation of HIF-1 Transcription Activity 0.95
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.95
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.89
RNA-seq analysis upon ARID1B overexpression 0.87
EGR1-controlled transcriptome of T HESCs 0.85
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.85
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.84
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.81
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.79
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.78
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.75
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.75
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.74
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.74
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.67
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.63
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.61
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.61
RNA-seq differential expression studies: more sequence, or more replication? 0.59
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.57
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.56
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.53
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.53
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.49
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.49
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.49
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.49
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.43
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.4
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 0.39
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.38
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.34
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.34
Profiling of escape kinetics of viruses subjected to RNAi 0.33
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.32
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.29
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.25
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.25
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.24
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.24
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.24
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.2
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.15
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.14
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.09
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.07
The DPYSL2 gene connects mTOR and schizophrenia 0.06
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.03
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation